AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26465829 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (233 mg zinc gluconate containing 30 mg zinc) for 6 weeks
Number of subjects: 50
Study 26465829 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 weeks
Number of subjects: 50
Study 24671361 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic reminders during the second period
Number of subjects: 0
Study 24671361 — intervention group
Group type: COMPARATOR
Intervention: Control group (no electronic reminders)
Number of subjects: 0
Study 23065038 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 469
Study 23065038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 469
Study 20650926 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen
Number of subjects: 60
Study 20650926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 17543812 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine infusion (50 hours)
Number of subjects: 84
Study 17543812 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (50 hours)
Number of subjects: 84
Study 16118753 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-assisted total hip arthroplasty
Number of subjects: 71
Study 16118753 — intervention group
Group type: COMPARATOR
Intervention: Conventional total hip arthroplasty
Number of subjects: 71
Study 11982742 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) 60 mg day -1
Number of subjects: 14
Study 10441040 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg/kg (b.w.) of nicotinamide (NA)
Number of subjects: 74
Study 10441040 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/kg (b.w.) of nicotinamide (NA)
Number of subjects: 74
Study 10441040 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses of nicotinamide (25 mg/kg and 50 mg/kg)
Number of subjects: 74
Study 8929228 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifemelane (CAS 90293‐01‐9)
Number of subjects: 18
Study 8929228 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 2077983 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.4 mg/kg
Number of subjects: 60
Study 2077983 — intervention group
Group type: COMPARATOR
Intervention: Diazepam 0.75 mg/kg
Number of subjects: 60
Study 348536 — intervention group
Group type: COMPARATOR
Intervention: Metopimazine 30 mg/day or 15 mg/day
Number of subjects: 183
Study 348536 — intervention group
Group type: COMPARATOR
Intervention: Metopimazine 45 mg/day
Number of subjects: 183
Study 31123552 — intervention group
Group type: EXPERIMENTAL
Intervention: Fab antivenom (FabAV)
Number of subjects: 74
Study 31123552 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 28211112 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct marketing price promotion (Buywell) combined with healthy eating advice and recipe suggestions
Number of subjects: 53367
Study 28211112 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct marketing price promotion (Buywell)
Number of subjects: 53367
Study 25659142 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeless‐tailored service design
Number of subjects: 366
Study 25659142 — intervention group
Group type: COMPARATOR
Intervention: Mainstream primary care clinics (VA)
Number of subjects: 366
Study 25659142 — intervention group
Group type: COMPARATOR
Intervention: Tailored non‐VA healthcare program
Number of subjects: 366
Study 24072965 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered psychoeducational intervention (12 sessions)
Number of subjects: 38
Study 24072965 — intervention group
Group type: COMPARATOR
Intervention: Control group (DVD containing educational information about dementia caregiving)
Number of subjects: 38
Study 21332450 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate catheter removal
Number of subjects: 70
Study 21332450 — intervention group
Group type: COMPARATOR
Intervention: Delayed catheter removal
Number of subjects: 70
Study 19236356 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine treatment for heroin dependence
Number of subjects: 62
Study 16445448 — intervention group
Group type: EXPERIMENTAL
Intervention: Limbal anaesthesia
Number of subjects: 117
Study 16445448 — intervention group
Group type: COMPARATOR
Intervention: Topical anaesthesia
Number of subjects: 117
Study 15301642 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy (NET)
Number of subjects: 43
Study 15301642 — intervention group
Group type: COMPARATOR
Intervention: Supportive Counseling (SC)
Number of subjects: 43
Study 15301642 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation (PE)
Number of subjects: 43
Study 10742705 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise programme (once weekly sessions for 12 weeks)
Number of subjects: 22
Study 10742705 — intervention group
Group type: COMPARATOR
Intervention: Control component
Number of subjects: 22
Study 9076618 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice-based oral rehydration solution (ORS)
Number of subjects: 100
Study 9076618 — intervention group
Group type: COMPARATOR
Intervention: Glucose oral rehydration solution (ORS)
Number of subjects: 100
Study 8376450 — intervention group
Group type: EXPERIMENTAL
Intervention: Chevron metatarsal osteotomy
Number of subjects: 51
Study 8376450 — intervention group
Group type: COMPARATOR
Intervention: Wilson metatarsal osteotomy
Number of subjects: 51
Study 3024869 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine (cholinergic blockade)
Number of subjects: 6
Study 3024869 — intervention group
Group type: COMPARATOR
Intervention: Control (no atropine)
Number of subjects: 6
Study 30858203 — intervention group
Group type: EXPERIMENTAL
Intervention: Daptomycin plus Ceftaroline (DAPCPT) - 6 to 8 mg/kg of body weight per day of DAP and 600 mg intravenous CPT every 8 hours (n 17)
Number of subjects: 40
Study 30858203 — intervention group
Group type: COMPARATOR
Intervention: Standard monotherapy - Vancomycin (VAN; dosed to achieve serum trough concentrations of 15 to 20 mg/liter; n 21) or 6 to 8 mg/kg/day DAP (n 2) (n 23 total)
Number of subjects: 40
Study 30858203 — intervention group
Group type: EXPERIMENTAL
Intervention: Daptomycin plus Ceftaroline (DAPCPT) - among patients with IL-10 concentration of 5 pg/ml (n 14)
Number of subjects: 40
Study 30858203 — intervention group
Group type: COMPARATOR
Intervention: Standard monotherapy - among patients with IL-10 concentration of 5 pg/ml (n 19)
Number of subjects: 40
Study 29993140 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised oral health examination by registered dental hygienists
Number of subjects: 559
Study 26625401 — intervention group
Group type: EXPERIMENTAL
Intervention: NeuCube SNN model
Number of subjects: 3
Study 26625401 — intervention group
Group type: COMPARATOR
Intervention: Traditional statistical and artificial intelligence methods
Number of subjects: 3
Study 24648103 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-item clinical prediction rule for recovery from acute LBP
Number of subjects: 956
Study 22686185 — intervention group
Group type: EXPERIMENTAL
Intervention: 18 months of weekly psychoanalytic psychotherapy, manualised and fidelity‐assessed using the Psychotherapy Process Q‐Sort.
Number of subjects: 0
Study 22686185 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual, managed by the referring practitioner.
Number of subjects: 0
Study 20830664 — intervention group
Group type: EXPERIMENTAL
Intervention: Desvenlafaxine (50, 100, 200, or 400 mg/d)
Number of subjects: 0
Study 20830664 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18555464 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose chemotherapy (HDCT) with melphalan 200 mg/m² and autologous peripheral stem cell transplantation (APSCT)
Number of subjects: 37
Study 18555464 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide maintenance therapy at 100 mg/day
Number of subjects: 37
Study 15751598 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory community-media intervention
Number of subjects: 0
Study 15751598 — intervention group
Group type: EXPERIMENTAL
Intervention: Key informant community readiness assessments
Number of subjects: 0
Study 11843743 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 180
Study 11843743 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 180
Study 10382465 — intervention group
Group type: EXPERIMENTAL
Intervention: Early discharge follow-up program
Number of subjects: 639
Study 10382465 — intervention group
Group type: COMPARATOR
Intervention: Standard care (before the program)
Number of subjects: 639
Study 7586952 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine (1, 2, and 4 micrograms/kg)
Number of subjects: 7
Study 7586952 — intervention group
Group type: COMPARATOR
Intervention: Phentolamine (10 mg, intravenous)
Number of subjects: 7
Study 7586952 — intervention group
Group type: COMPARATOR
Intervention: Prazosin (5 mg, orally)
Number of subjects: 7
Study 7586952 — intervention group
Group type: COMPARATOR
Intervention: Nicardipine (2 micrograms/kg/min, continuous intravenous infusion)
Number of subjects: 7
Study 2254715 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 52
Study 2254715 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple injections (MI) with human isophane insulin
Number of subjects: 52
Study 2254715 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (CT)
Number of subjects: 52
Study 2254715 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple injections (MI) with human ultralente insulin
Number of subjects: 52
Study 2254715 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified therapy (CSII and MI)
Number of subjects: 52
Study 2254715 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified insulin therapy (CSII and MI)
Number of subjects: 52
Study 7029388 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 1% aqueous indomethacin
Number of subjects: 0
Study 7029388 — intervention group
Group type: COMPARATOR
Intervention: Control group (no indomethacin)
Number of subjects: 0
Study 31646414 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose spinal analgesia (levobupivacaine 7.5 mg plus sufentanil 2.5 μg)
Number of subjects: 102
Study 31646414 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose spinal analgesia (levobupivacaine 3.75 mg plus sufentanil 2.5 μg)
Number of subjects: 102
Study 31646414 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia alone
Number of subjects: 102
Study 31646414 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose spinal analgesia during laparoscopy
Number of subjects: 102
Study 31646414 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose spinal analgesia during laparoscopy
Number of subjects: 102
Study 31646414 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia during laparoscopy
Number of subjects: 102
Study 31318233 — intervention group
Group type: EXPERIMENTAL
Intervention: go/no-go training with smoking stimuli
Number of subjects: 107
Study 31318233 — intervention group
Group type: COMPARATOR
Intervention: go/no-go training with nonsmoking stimuli (control)
Number of subjects: 107
Study 28295463 — intervention group
Group type: EXPERIMENTAL
Intervention: RG-101 2 mg/kg (n = 14)
Number of subjects: 32
Study 28295463 — intervention group
Group type: EXPERIMENTAL
Intervention: RG-101 4 mg/kg (n = 14)
Number of subjects: 32
Study 28295463 — intervention group
Group type: EXPERIMENTAL
Intervention: RG-101 (both dosages combined)
Number of subjects: 32
Study 28295463 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 2)
Number of subjects: 32
Study 26354535 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight variability measured over the initial 6 months using root mean square error approach.
Number of subjects: 171
Study 26354535 — intervention group
Group type: COMPARATOR
Intervention: Control for baseline body mass index (BMI) and BMI change from baseline to 6 months, as well as measures of disinhibition, restrained eating, and dieting.
Number of subjects: 171
Study 23685845 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil treatment
Number of subjects: 44
Study 23685845 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil treatment in ED/DM group
Number of subjects: 44
Study 23685845 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 44
Study 21271365 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention
Number of subjects: 0
Study 21271365 — intervention group
Group type: EXPERIMENTAL
Intervention: Public web site
Number of subjects: 0
Study 21271365 — intervention group
Group type: COMPARATOR
Intervention: Survey-only group
Number of subjects: 0
Study 19898073 — intervention group
Group type: EXPERIMENTAL
Intervention: Unstable sandals for 6 weeks
Number of subjects: 40
Study 19898073 — intervention group
Group type: COMPARATOR
Intervention: Regular golf shoes for 6 weeks (Control)
Number of subjects: 40
Study 17943620 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational telephone counseling intervention (MI)
Number of subjects: 358
Study 17943620 — intervention group
Group type: EXPERIMENTAL
Intervention: Three MI calls
Number of subjects: 358
Study 17943620 — intervention group
Group type: COMPARATOR
Intervention: No telephone calls
Number of subjects: 358
Study 15569128 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured reinforcement of diabetic health education by a trained nurse every 3 months
Number of subjects: 180
Study 15569128 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care without nursing reinforcement
Number of subjects: 180
Study 11139544 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (400 microgram, vaginally)
Number of subjects: 274
Study 11139544 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274
Study 11139544 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (in clomiphene cycles)
Number of subjects: 274
Study 11139544 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (in FSH cycles)
Number of subjects: 274
Study 11139544 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (in natural cycles)
Number of subjects: 274
Study 11139544 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (in clomiphene/FSH cycles)
Number of subjects: 274
Study 11139544 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 274
Study 9022526 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (clamping when the cord stopped pulsating, infant at the level of the placenta)
Number of subjects: 69
Study 9022526 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (clamping when the cord stopped pulsating, newborn below the level of the placenta)
Number of subjects: 69
Study 9022526 — intervention group
Group type: COMPARATOR
Intervention: Immediate cord clamping (control group)
Number of subjects: 69
Study 8154425 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 25
Study 8154425 — intervention group
Group type: COMPARATOR
Intervention: Nitroglycerin (GTN)
Number of subjects: 25
Study 8154425 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 25
Study 3127431 — intervention group
Group type: EXPERIMENTAL
Intervention: Rioprostil 60, 120, and 300 micrograms four times per day
Number of subjects: 56
Study 3127431 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 31666995 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm-up with post-activation potentiation (PAP) sets (2 × 5 repetitions of unloaded countermovement jump)
Number of subjects: 16
Study 31666995 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm-up with post-activation potentiation (PAP) sets
Number of subjects: 16
Study 31666995 — intervention group
Group type: COMPARATOR
Intervention: Standard warm-up (non-PAP; control condition)
Number of subjects: 16
Study 30153859 — intervention group
Group type: EXPERIMENTAL
Intervention: suPAR measurement at arrival in emergency department
Number of subjects: 16801
Study 30153859 — intervention group
Group type: COMPARATOR
Intervention: No suPAR measurement in emergency department
Number of subjects: 16801
Study 30153859 — intervention group
Group type: EXPERIMENTAL
Intervention: suPAR measurement
Number of subjects: 16801
Study 26337285 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin initiation checklist
Number of subjects: 64
Study 26337285 — intervention group
Group type: COMPARATOR
Intervention: Control group (no checklist)
Number of subjects: 64
Study 25220898 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain that at least moderately interfered with daily living
Number of subjects: 699
Study 23194489 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial fibrillation/flutter (AF/AFL)
Number of subjects: 4133
Study 23194489 — intervention group
Group type: COMPARATOR
Intervention: Sinus rhythm (SR)
Number of subjects: 4133
Study 20162301 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Water Immersion (CWI) 14 degrees C
Number of subjects: 10
Study 18607311 — intervention group
Group type: EXPERIMENTAL
Intervention: SAFE intervention
Number of subjects: 477
Study 18607311 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 477
Study 15869558 — intervention group
Group type: EXPERIMENTAL
Intervention: Home physiotherapy (pre- and post-operative home visits by a community physiotherapist)
Number of subjects: 160
Study 15869558 — intervention group
Group type: COMPARATOR
Intervention: Hospital outpatient physiotherapy
Number of subjects: 160
Study 15022656 — intervention group
Group type: EXPERIMENTAL
Intervention: True acupuncture interventions
Number of subjects: 47
Study 15022656 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture interventions
Number of subjects: 47
Study 10327378 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine 25 mg
Number of subjects: 23
Study 10327378 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 23
Study 10327378 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 7562355 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable matrix barrier (test)
Number of subjects: 38
Study 7562355 — intervention group
Group type: COMPARATOR
Intervention: Nonresorbable expanded polytetrafluoroethylene (ePTFE) barrier (control)
Number of subjects: 38
Study 7562355 — intervention group
Group type: COMPARATOR
Intervention: Control treatment (nonresorbable barrier)
Number of subjects: 38
Study 2075848 — intervention group
Group type: EXPERIMENTAL
Intervention: Televised self-help cigarette smoking cessation intervention
Number of subjects: 0
Study 2075848 — intervention group
Group type: EXPERIMENTAL
Intervention: Attending three weekly support meetings during the program
Number of subjects: 0
Study 2075848 — intervention group
Group type: COMPARATOR
Intervention: Not attending support meetings
Number of subjects: 0
Study 2075848 — intervention group
Group type: EXPERIMENTAL
Intervention: Meeting sample
Number of subjects: 0
Study 2075848 — intervention group
Group type: COMPARATOR
Intervention: Other sample (not attending meetings)
Number of subjects: 0
Study 7033946 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg metoprolol
Number of subjects: 27
Study 7033946 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg indapamide
Number of subjects: 27
Study 7033946 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 200 mg metoprolol and 2.5 mg indapamide
Number of subjects: 27
Study 31980886 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine infusion (1.5 mg/kg bolus followed by 1.5 mg/kg/h continuous infusion)
Number of subjects: 48
Study 31980886 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 48
Study 31796179 — intervention group
Group type: EXPERIMENTAL
Intervention: Afoxolaner (2.7-6.9 mg/kg, PO)
Number of subjects: 16
Study 31796179 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin (300 μg/kg, SC)
Number of subjects: 16
Study 31796179 — intervention group
Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 16
Study 31796179 — intervention group
Group type: EXPERIMENTAL
Intervention: Afoxolaner (monthly treatment for heavy infestations)
Number of subjects: 16
Study 29090299 — intervention group
Group type: EXPERIMENTAL
Intervention: Palm oil (PO, 22.25 g)
Number of subjects: 18
Study 29090299 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice bran oil (RBO, 22.25 g)
Number of subjects: 18
Study 29090299 — intervention group
Group type: EXPERIMENTAL
Intervention: Palm oleogel (PG, 22.25 g oil + 2.75 g EC)
Number of subjects: 18
Study 29090299 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice bran oleogel (RBG, 22.25 g oil + 2.75 g EC)
Number of subjects: 18
Study 29090299 — intervention group
Group type: COMPARATOR
Intervention: No oil control
Number of subjects: 18
Study 26534948 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-dive checklist and post-dive log
Number of subjects: 1043
Study 26534948 — intervention group
Group type: COMPARATOR
Intervention: Post-dive log only
Number of subjects: 1043
Study 24906838 — intervention group
Group type: COMPARATOR
Intervention: Nutrition counseling during radiotherapy, with at least three sessions of individualized dietary counseling.
Number of subjects: 87
Study 24906838 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition counseling during radiotherapy.
Number of subjects: 87
Study 22196424 — intervention group
Group type: EXPERIMENTAL
Intervention: High-velocity low-amplitude (HVLA) manipulation to the SIJ
Number of subjects: 32
Study 22196424 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SIJ and lumbar HVLA manipulation
Number of subjects: 32
Study 19394503 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (0.5 microg/kg/min continuous infusion)
Number of subjects: 100
Study 19394503 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 100
Study 17533211 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin Choice decision aid
Number of subjects: 98
Study 17533211 — intervention group
Group type: COMPARATOR
Intervention: Control pamphlet about cholesterol management
Number of subjects: 98
Study 15232500 — intervention group
Group type: EXPERIMENTAL
Intervention: 5,000 U of Botulinum toxin type B (BTX-B) treatment
Number of subjects: 14
Study 15232500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 12368670 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreatic duct occlusion without anastomosis
Number of subjects: 169